Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Change In Receivables
\$0.06 Mil (As of Mar. 2015)

Synageva BioPharma Corp's change in receivables for the quarter that ended in Mar. 2015 was \$0.06 Mil. It means Synageva BioPharma Corp's accounts receivables increased by \$0.06 Mil from Dec. 2014 to Mar. 2015 .

Synageva BioPharma Corp's change in receivables for the fiscal year that ended in Dec. 2014 was \$0.39 Mil. It means Synageva BioPharma Corp's accounts receivables increased by \$0.39 Mil from Dec. 2013 to Dec. 2014 .

Synageva BioPharma Corp's accounts receivables for the quarter that ended in Mar. 2015 was \$0.93 Mil.

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed. Synageva BioPharma Corp's days sales outstanding for the three months ended in Mar. 2015 was 91.15.

In Ben Grahams calculation of liquidation value, Apple Inc's accounts receivables are only considered to be worth 75% of book value. Synageva BioPharma Corp's liquidation value for the three months ended in Mar. 2015 was \$677.84 Mil.

Definition

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Synageva BioPharma Corp's Days Sales Outstanding for the quarter that ended in Mar. 2015 is calculated as:

 Days Sales Outstanding = Account Receivable / Revenue * Days in Period = 0.926 / 0.927 * 91 = 91.15

2. In Ben Grahams calculation of liquidation value, Synageva BioPharma Corp's accounts receivable are only considered to be worth 75% of book value:

Synageva BioPharma Corp's liquidation value for the quarter that ended in Mar. 2015 is calculated as:

 Liquidation Value = Cash and Cash Equivalents - Total Liabilities + (0.75 * Account Receivable) + (0.5 * Inventory) = 710.561 - 33.42 + 0.75 * 0.926 + 0.5 * 0 = 677.84

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 ChangeInReceivables -4.50 -2.82 0.57 9.42 0.41 -0.80 1.59 -0.39 1.23 0.39

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 ChangeInReceivables 0.02 0.01 -1.21 2.66 -0.23 -0.07 -0.80 0.88 0.38 0.06
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)